Europe Medical Collagen Market

Market Introduction

Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry.

Europe Medical Collagen Strategic Insights

Strategic insights for the Europe Medical Collagen provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Medical Collagen Report Scope

Europe Medical Collagen Regional Insights

The geographic scope of the Europe Medical Collagen refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Europe medical collagen market is expected to reach US$ 255.72 million in 2028 from US$ 175.11 million in 2021; it is estimated to register a CAGR of 5.6% from 2021 to 2028. The growth of the Europe medical collagen market is attributable to increasing research activities for collagen-based medical products, rising FDA approvals, and product launches. However, availability of efficient and reliable substitute biomaterials are hindering the growth of the market.

 A medical product with collagen as a part is being studied to treat several conditions. Owing to its clinical and consumer acceptance, it is widely used as a medical material. Collagen-based medical products such as bioprosthetic heart valves, arterial replacements, sutures used in surgical procedures, and wound dressings have been widely adopted. Thus, several research studies are being conducted to develop new collagen-based medical products. For instance, in 2020, MPM Medical initiated its CoMatryx Surgical Bovine Collagen Study. CoMatryx surgical collagen powder is a soft tissue repair product made of 100% Type-I Bovine collagen. Furthermore, research is being conducted to discover new sources of collagen for medical biomaterials. For instance, the study ‘Tilapia (Oreochromis aureus) Collagen for Medical Biomaterials’ was published in 2018. The researchers studied the potentials of tilapia skin as an alternative source of collagen for its application in the medical biomaterial. Thus, the increasing research activities for collagen-based medical products are likely to drive the growth of the market during the forecast period. Also, various players operating in the medical collagen market are developing and launching new products to expand their geographic reach and capacity to cater to many customers. Thus, constant advancements in medical collagen products and approvals regulatory bodies are factors further driving the growth of the medical collagen market.

Europe has been witnessing a growing number of COVID-19 cases since its outbreak. However, the health and wellness market in Europe is observing steady growth due to the outbreak of COVID-19. Collagen peptides are among the products gaining excellent popularity during the pandemic. Europeans are looking at different and natural ways for staying healthy and enhancing their immune system. So, there is increased interest in how collagen peptides can enhance vitamins and health supplements and help people with their health and wellness amid the pandemic.  Also, due to social distancing practices, consumers are experiencing changes to their daily routines involving grooming and skincare. This has led to an increased demand for nutricosmetics that can be used at home. This is likely to drive the growth of skincare collagen products. Hence, COVID-19 has had a positive impact on the Europe medical collagen market.

Key Market Segments

The Europe medical collagen market, by source, is segmented into bovine, porcine, and others. The bovine segment held the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period.

The Europe medical collagen market, by product, is segmented into gelatine, hydrolysed collagen, native collagen, and others. The gelatine segment held the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period.

Based on application, the Europe medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and others. The wound care segment held the largest share of the market in 2020. However, the bone grafts segment is estimated to register the highest CAGR during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Europe medical collagen market are the European Medicines Agency (EMA), European Union (EU) and Spanish National Health System (SNHS).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Europe medical collagen market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Europe medical collagen market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe medical collagen market.

EUROPE MEDICAL COLLAGEN MARKET SEGMENTATION

By Source

• Bovine
• Porcine
• Others

By Product

• Gelatine
• Hydrolysed Collagen
• Native Collagen
• Others

By Application

• Wound Care
• Bone Grafts
• Tissue Scaffolds
• Cartilage Repair
• Haemostats
• Diagnostics
• Vascular Grafts
• Other

By Country

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Company Profiles

• DSM
• Collagen Solutions Plc
• SYMATESE
• Innocoll Pharmaceuticals
• ENCOLL Corp
• CollPlant Biotechnology
• GELITA AG
• Collagen Matrix, Inc.
• Integra Life Sciences Corporation
• Croda International plc